In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in Healthy Subjects

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

May 31, 2025

Conditions
Cardio-protection
Interventions
DIETARY_SUPPLEMENT

High Dose of Vitamin C with ir without 50 mg of flavonoids

The anti-inflammatory and anti-platelet efficacy and synergy of a supplement containing high dose (1 g) of vitamin C and a low dose (50 mg) citrus and rose bioflavonoids (VCF), was assessed in platelets of blood samples collected from healthy subjects, prior the oral administration (t=0 days) and just after this administration for 1 month (VCF Group), VERSUS the findings from the same procedure contacted for a supplement containing only high dose (1 g) of vitamin C (VC Group)

Trial Locations (1)

65404

School of Chemistry, Faculty of Sciences, Democritus University of Thrace, Kavala

All Listed Sponsors
lead

Democritus University of Thrace

OTHER

NCT07061431 - In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in Healthy Subjects | Biotech Hunter | Biotech Hunter